Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgolide Capsules for Stable Angina Pectoris
CTR20131234Phase 2Active
- Sponsor
- Hefei Innovation Pharmaceutical Technology
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ginkgolide in coronary arteriosclerosis, angina pectoris, sponsored by Hefei Innovation Pharmaceutical Technology. Started Nov 2013; status: active.
02
Drugs
Ginkgolide
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on CTR20131234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131234.